Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
05/2009
05/19/2009US7534445 isolated nucleotide sequences and degenerate sequences encoding the high molecular weight HMW protein; vaccines; antibodies; vectors
05/19/2009US7534444 Molecular mimetics of meningococcal B epitopes which elicit functionally active antibodies
05/19/2009US7534440 Fusion molecules and methods for treatment of immune diseases
05/19/2009US7534432 Suppressing acitivity to treat musculodegenerative disease
05/19/2009US7534425 As well as Paget's disease, neurological/neuromuscular diseases, nerve diseases, and/or psychotropic diseases; chloride channel modulators
05/19/2009US7534424 Optimizing the dosage of a therapeutic nucleic acid by using doxorubicin which is known to deplete liver macrophages known as Kupffer cells, thereby reducing liver toxicity
05/19/2009CA2367955C Abc1 polypeptide and methods and reagents for modulating cholesterol levels
05/19/2009CA2323237C Improved radiation therapy methods
05/19/2009CA2318029C Apo-2 ligand
05/19/2009CA2230511C Flowering genes
05/19/2009CA2224130C Nicotianamine aminotransferase and gene therefor
05/19/2009CA2209167C Hydroxylamine derivatives useful for enhancing the molecular chaperon production and the preparation thereof
05/14/2009WO2009062143A2 Methods for the repair and/or regeneration of damaged myocardium using variants of hepatocyte growth factor
05/14/2009WO2009062050A2 Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers
05/14/2009WO2009062001A1 Stimulation of anti-tumor immunity using dendritic cell/tumor cell fusions and anti-cd3/cd28
05/14/2009WO2009061837A1 Neoplastic stem cell system and method
05/14/2009WO2009061725A2 Vascular repair and endothelial cells
05/14/2009WO2009061500A1 Use of lingo-4 antagonists in the treatment of conditions involving demyelination
05/14/2009WO2009061334A1 Tissue-engineered endothelial and epithelial implants differentially and synergistically regulate tissue repair
05/14/2009WO2009061215A1 Compositions and methods for altering pigment production in plants
05/14/2009WO2009061214A1 Compositions and methods for modulating pigment production in plants
05/14/2009WO2009061024A1 Method for isolating and culturing adult stem cells derived from human amniotic epithelium
05/14/2009WO2009060961A1 West nile virus vaccine, and method for production thereof
05/14/2009WO2009060864A1 Three-dimensionally cultured elastic fiber tissue and method of producing three-dimensionally cultured elastic fiber tissue
05/14/2009WO2009060402A2 Plant promoters of the xvsap1 gene
05/14/2009WO2009060184A1 Mycobacterium antigens
05/14/2009WO2009060129A1 Human monoclonal antibodies directed to sialyl lewis c, sialyl tn and n-glycolylneuraminic acid epitopes and a method of analysis of stem cells comprising said epitopes
05/14/2009WO2009059804A2 T-cell receptor peptides specific for part of cd20, uses thereof, and methods of preparing cytotoxic t-cells
05/14/2009WO2009059411A1 Porcine lung epithelial cell line and its use in production and detection of porcine reproductive and respiratory syndrome virus
05/14/2009WO2009042162A3 Compositions and methods for inhibiting interleukin pathways
05/14/2009WO2009040457A3 Cellular cryopreservation by means of vitrification with low concentrations of cryoprotector
05/14/2009WO2009010841A8 Culture for expanding stem cells ex-vivo
05/14/2009WO2008157394A3 Regulatory t cells and methods of making and using same
05/14/2009WO2008155028A9 Method and device for forming a three-dimensional arrangement of biological cells
05/14/2009WO2008127352A3 Knockout mice for pr01105, pro1279 or pro1783 coding genes
05/14/2009WO2008063092A3 Microstructural protein preparations containing adsorbed biologically active substances and their application in medicine and cosmetics
05/14/2009WO2007047581A3 Pulmonary stem cells, related methods and kits
05/14/2009WO2007038056A3 Protease-resistant forms of vegf-d, method of making and method of use
05/14/2009WO2006052925A3 Cardiac stem cells
05/14/2009WO2005115469A3 Estrogen modulation of ifn-gamma-mediated conditions and diseases
05/14/2009WO2005113809A3 Novel fibroblast growth factor and nucleic acids encoding same
05/14/2009WO2005046447A3 Method to control ventricular rate in atrial fibrillation patients
05/14/2009US20090126046 Plants having improved growth characteristics and method for making the same
05/14/2009US20090126044 Synthetic genes encoding cry1ac
05/14/2009US20090126042 for improving fiber quality and/or yield of a fiber producing plant, as well as methods of using such polynucleotides for producing plants having increased biomass/vigor/yield
05/14/2009US20090126041 Regeneration
05/14/2009US20090126038 Rna constructs
05/14/2009US20090126037 Tomtato plants having higher levels of resistance to botrytis
05/14/2009US20090126035 Rice Hybrid XL729
05/14/2009US20090126034 Environmentally Stable Sensors and Methods of Using the Same
05/14/2009US20090126032 Method to produce cloned embryos and adults from cultured cells
05/14/2009US20090124795 Mitochondrial Dosimeter
05/14/2009US20090124777 Compositions for Delivering Nucleic Acids to Cells
05/14/2009US20090124695 Prostaglandin e1 and e2 analogs for the treatment of various medical conditions
05/14/2009US20090124685 Agave syrup extract having anticancer activity
05/14/2009US20090124683 Mercaptan and seleno-mercaptan compounds and methods of using them
05/14/2009US20090124675 Inhibitors of anti-apoptotic proteins
05/14/2009US20090124569 Inhibition and treatment of prostate cancer metastasis
05/14/2009US20090124568 Use of stem cells to generate inner ear cells
05/14/2009US20090124567 Influenza Therapeutic
05/14/2009US20090124564 Compositions and methods for regulating apoptosis
05/14/2009US20090124543 Activity dependent neurotrophic factor iii (adnf iii)
05/14/2009US20090124542 Methods and reagents for treatment and diagnosis of age-related macular degeneration
05/14/2009US20090124538 Selective R-cadherin antagonists and methods
05/14/2009US20090124534 Trehalose Click Polymers for Delivery of Biologically Active Molecules
05/14/2009US20090124022 Antibodies that bind to mammalian ngal and uses thereof
05/14/2009US20090124013 Stem-Like Cells
05/14/2009US20090124012 Toxin/antitoxin systems and methods for regulating cellular growth, metabolic engineering and production of recombinant proteins
05/14/2009US20090124011 Serum Production System
05/14/2009US20090124010 Peptide Fractions Promoting Growth and Synthesis of Desired Product (S) Into Cell and/or Tissue Culture
05/14/2009US20090124009 Antisense modulation of ptp1b expression
05/14/2009US20090124008 Peptides for use in culture media
05/14/2009US20090124007 Method for the Simultaneous Primary-Isolation and Expansion of Endothelial Stem/Progenitor Cell and Mesenchymal Stem Cell Derived From Mammal Including Human Umbilical Cord
05/14/2009US20090124006 Serum-Free Culture Medium for the Production of Recombinant Gonadotropins
05/14/2009US20090124005 cell comprising an expression-enhancing sequence selected from SEQ ID NO:1-6, and at least one recombinase recognition site located immediately adjacent to SEQ ID NO:1-6
05/14/2009US20090124004 Insect desiccation resistance genes and uses thereof
05/14/2009US20090124003 Modulators of odorant receptors
05/14/2009US20090124002 Alpha-1d calcium channel expressed in atrium
05/14/2009US20090124001 9-amino-acridine derivatives and their use for eliminating misfolded proteins
05/14/2009US20090123999 Nucleotide sequences invovled in plant disease resistance
05/14/2009US20090123997 Modulators of odorant receptors
05/14/2009US20090123991 Retrons for gene targeting
05/14/2009US20090123984 Transformed plants accumulating terpenes
05/14/2009US20090123975 Feed media
05/14/2009US20090123974 Rational evolution of cytokines for higher stability, the cytokines and encoding nucleic acid molecules
05/14/2009US20090123973 Methods of Making Modular Fusion Protein Expression Products
05/14/2009US20090123971 Compositions of aminoacyl-tRNA synthetase and uses thereof
05/14/2009US20090123970 Glycosylated mammalian ngal and use thereof
05/14/2009US20090123969 Novel fluorescent protein and gene encoding the same
05/14/2009US20090123967 Modified spider silk proteins
05/14/2009US20090123963 Biopsy sample mount and processing method
05/14/2009US20090123954 Multicolor bioluminescent visualization probe set, or single-molecule-format multicolor bioluminescent visualization probe
05/14/2009US20090123953 Double brilliance beta-arrestin: a biosensor for monitoring the activity of receptors and signalling molecules, and method of using same
05/14/2009US20090123945 Cholinergic/serotoninergic receptor and uses thereof
05/14/2009US20090123944 Bioassays
05/14/2009US20090123942 Electrophysiological assays using oocytes that express human enac and the use of phenamil to improve the effect of enac enhancers in assays using membrane potential reporting dyes
05/14/2009US20090123938 Contacting a candidate antagonist with a MCP-1 receptor polypeptide having an amino acid sequence at least 95% homologous to an extracellular domain of a specific sequence, and comparing the binding of MCP-1 to the receptor polypeptide; decreased binding indicates an antagonist
05/14/2009US20090123936 Conformationally abnormal forms of tau proteins and specific antibodies thereto
05/14/2009US20090123934 Inhibition of polo kinase by matrimony maintains G2 arrest in the meiotic cell cycle
05/14/2009US20090123927 Isolation of precursor cells and their use for tissue repair
1 ... 591 592 593 594 595 596 597 598 599 600 601 602 603 604 605 606 607 608 609 610 611 ... 1827